Fingerprint
Dive into the research topics of 'Lucitanib for the treatment of HR+/HER2- metastatic breast cancer: results from the multicohort phase II FINESSE study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Lucitanib for the treatment of HR+/HER2- metastatic breast cancer: results from the multicohort phase II FINESSE study
Rina Hui, Alex Pearson, Javier Cortes, Christine Campbell, Camille Poirot, Hatem A Azim, Debora Fumagalli, Matteo Lambertini, Fergus Daly, Amal Arahmani, José Perez-Garcia, Philippe Aftimos, Philippe L Bedard, Laura Xuereb, Elsemieke D Scheepers, Malou Vicente, Theodora Goulioti, Sibylle Loibl, Sherene Loi, Marie-Jeanne Pierrat
Research output: Contribution to journal › Article › peer-review